Palatin Technologies
Patents, Design & Utilities
Last updated:
List of all Palatin Technologies patents 10 in total
| Status | Patent |
|---|---|
Application | Utility: Orally Active Melanocortin Receptor-4 Compounds Filling date: 8 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: Melanocortin Receptor-Specific Peptide Formulations and Methods for Gastrointestinal Tract-Specific Delivery Filling date: 8 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: USE OF BREMELANOTIDE IN PATIENTS WITH CONTROLLED HYPERTENSION Filling date: 8 Sep 2025 Issue date: 22 Jul 2021 |
Application | Utility: Orally Active Melanocortin Receptor-4 Compounds Filling date: 8 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: USES OF BREMELANOTIDE IN THERAPY FOR FEMALE SEXUAL DYSFUNCTION Filling date: 8 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: Melanocortin-1 Receptor-Specific Peptides for Cytokine Storm and Inflammation Therapy Filling date: 8 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: Therapies for Obesity, Diabetes and Related Indications Filling date: 8 Sep 2025 Issue date: 3 Sep 2020 |
Grant | Utility: Melanocortin receptor-specific peptide with C-terminal naphthylalanine Filling date: 8 Sep 2025 Issue date: 14 Jul 2020 |
Grant | Utility: Therapies for obesity, diabetes and related indications Filling date: 8 Sep 2025 Issue date: 26 May 2020 |
Grant | Utility: Melanocortin receptor-specific peptides Filling date: 8 Sep 2025 Issue date: 28 Apr 2020 |
Showing 1 to 10 of 10 patents.